A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ethyl loflazepate
Resveratrol
The risk or severity of bleeding can be increased when Acemetacin is combined with Resveratrol.
Ethyl loflazepate
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Acemetacin.
Ethyl loflazepate
Propacetamol
The risk or severity of adverse effects can be increased when Propacetamol is combined with Acemetacin.
Ethyl loflazepate
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Acemetacin.
Ethyl loflazepate
Chenodeoxycholic acid
The metabolism of Acemetacin can be decreased when combined with Chenodeoxycholic acid.
Ethyl loflazepate
Polymyxin B
The risk or severity of adverse effects can be increased when Acemetacin is combined with Polymyxin B.
Ethyl loflazepate
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Acemetacin.
Ethyl loflazepate
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Acemetacin.
Ethyl loflazepate
Potassium triiodide
Potassium triiodide may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium carbonate
Potassium carbonate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium permanganate
Potassium permanganate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium guaiacolsulfonate
Potassium guaiacolsulfonate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium hydroxide
Potassium hydroxide may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium bitartrate
Potassium bitartrate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium lactate
Potassium lactate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Dipotassium phosphate
Dipotassium phosphate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Monopotassium phosphate
Monopotassium phosphate may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium alum
Potassium alum may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Potassium Iodide
Potassium Iodide may increase the hyperkalemic activities of Acemetacin.
Ethyl loflazepate
Nedaplatin
Acemetacin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3